<?xml version='1.0' encoding='utf-8'?>
<document id="26059917"><sentence text="Drug-drug interactions in pharmacologic management of gastroparesis." /><sentence text="Gastroparesis is a disorder characterized by delayed gastric emptying due to chronic abnormal gastric motility" /><sentence text=" The treatment of the disease often entails the co-administration of several classes of pharmacological agents" /><sentence text=" These agents may be metabolized via the same pathway" /><sentence text=" Inhibition or induction of a shared metabolic pathway leads to change in the systemic levels of prescribed drugs, possibly leading to undesired clinical outcomes" /><sentence text="" /><sentence text="This review discusses different pharmacological treatment for gastroparesis patients and describes the potential for drug-drug interactions (DDIs) in some of the combinations that are currently used" /><sentence text=" Prokinetic agents such as metoclopramide and domperidone are the cornerstone in treatment of gastroparesis"><entity charOffset="27-41" id="DDI-PubMed.26059917.s8.e0" text="metoclopramide" /><entity charOffset="46-57" id="DDI-PubMed.26059917.s8.e1" text="domperidone" /><pair ddi="false" e1="DDI-PubMed.26059917.s8.e0" e2="DDI-PubMed.26059917.s8.e0" /><pair ddi="false" e1="DDI-PubMed.26059917.s8.e0" e2="DDI-PubMed.26059917.s8.e1" /></sentence><sentence text=" Antiemetic agents such as promethazine and ondansetron are frequently administered to gastroparesis patients to reduce nausea and vomiting"><entity charOffset="27-39" id="DDI-PubMed.26059917.s9.e0" text="promethazine" /><entity charOffset="44-55" id="DDI-PubMed.26059917.s9.e1" text="ondansetron" /><pair ddi="false" e1="DDI-PubMed.26059917.s9.e0" e2="DDI-PubMed.26059917.s9.e0" /><pair ddi="false" e1="DDI-PubMed.26059917.s9.e0" e2="DDI-PubMed.26059917.s9.e1" /></sentence><sentence text=" Gastroparesis is prevalent in diabetic patients and therefore antidiabetic agents are also prescribed" /><sentence text=" Many of these co-administered drugs are metabolized via common drug metabolizing enzymes and this can trigger potential DDIs" /><sentence text=" The scientific literature was reviewed from the years 1975-2014 for original research articles and reviews that evaluated DDIs in gastroparesis" /><sentence text=" Many commonly prescribed combinations were predicted to cause potential DDIs in gastroparesis patients" /><sentence text=" This review will help inform about potential hazardous combinations" /><sentence text=" This information will hopefully lead to less adverse effects and more successful gastroparesis management" /><sentence text="" /></document>